Development of topical liposomes containing miltefosine for the treatment of Leishmania major infection in susceptible BALB/c mice

Leishmaniasis Worldwide and Global Estimates of Its Incidence

Jorge Alvar, Iván Darío Vélez, Caryn Bern et al. · PLoS ONE · 2012 · 5.1K citations · Full text

Parasitic Disease, Leishmaniasis Worldwide, Parasitic Protozoa +13

Oral Miltefosine for Indian Visceral Leishmaniasis

Shyam Sundar, T. K. Jha, C.P. Thakur et al. · New England Journal of Medicine · 2002 · 771 citations · Full text

Miltefosine for New World Cutaneous Leishmaniasis

Jaime Soto, Byron Arana, Julia Toledo et al. · Clinical Infectious Diseases · 2004 · 379 citations

Antiparasitic Agent, Medicine, Parasitic Protozoa +9

Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)

Naomi Aronson, Barbara L. Herwaldt, Michael Libman et al. · American Journal of Tropical Medicine and Hygiene · 2016 · 320 citations · Full text

Parasitic Disease, Parasitic Protozoa, Jan 2017 +6

Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH3 (edelfosine) and amphotericin B

Patricia Escobar, Sangeeta Matu, Cláudia N. H. Marques et al. · Acta Tropica · 2002 · 231 citations

Parasitic Disease, Bioorganic Chemistry, Biochemistry +11